|
|
|
|
|
|
|
Iradimed Cp (IRMD)
|
|
16.075 0.075 (0.47%)
|
04-25 15:59
|
|
Open:
|
16
|
Pre. Close:
|
16
|
|
High:
|
16.2
|
Low:
|
15.85
|
|
Volume:
|
6,746
|
Market Cap:
|
170M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
16.019 - 16.103
|
16.103 - 16.175
|
|
Low:
|
15.647 - 15.744
|
15.744 - 15.827
|
|
Close:
|
15.741 - 15.905
|
15.905 - 16.045
|
|
|
|
Technical analysis (as of: 2018-04-25 4:28:17 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 19.21 One year: 22.44
|
|
Support:
|
Support1: 14.78 Support2: 13.75
|
|
Resistance:
|
Resistance1:
16.45 Resistance2: 19.21
|
|
Pivot:
|
15.47 
|
|
Moving Averages:
|
MA(5): 15.79 MA(20): 15.18
MA(100): 14.36 MA(250): 11.71
|
|
MACD:
|
MACD(12,26):
0.49 Signal(12,26,9): 0.46
|
|
%K %D:
|
%K(14,3): 77.24 %D(3): 72.22
|
|
RSI:
|
RSI(14): 63.82
|
|
52-Week:
|
High: 16.45
Low: 8 Change(%): 79.7
|
|
Average Vol(K):
|
3-Month: 1029
10-Days 1132
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.IRMD has closed below upper band by 32.8%. Bollinger Bands are 32.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-02-06T17:20:05-05:00
IRADIMED's (IRMD) CEO Roger Susi on Q4 2017 Results - Earnings Call Transcript
2018-02-06T07:06:19-05:00
iRadimed beats by $0.04, beats on revenue
2018-01-22T08:23:11-05:00
IRADIMED announces Q1 and FY 2018 financial guidance
2017-11-28T07:43:47-05:00
Your Daily Pharma Scoop: Synergy In 2018, Repatha Action Date, Alkermes Signs Deal
2017-10-30T15:15:42-04:00
IRADIMED's (IRMD) CEO Roger Susi on Q3 2017 Results - Earnings Call Transcript
2017-10-30T07:19:35-04:00
iRadimed Q3 revenues off 26%; updates guidance
2017-10-30T07:04:31-04:00
iRadimed beats by $0.04, beats on revenue
2017-10-26T12:52:52-04:00
Midday Gainers / Losers
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
